PAREXEL and SHYFT Analytics Partner to Deliver Faster, More Dynamic Real-World Data Studies
Summary
The collaboration combines PAREXEL’s innovative scientific and clinical services with SHYFT’s market-leading suite of RWE products to provide insights and outcomes from patient-level data more efficiently to customers worldwide.PAREXEL will be leveraging the SHYFT platform to perform at-scale analyses including cohort modeling, trial feasibility assessment, and large scale observational studies - research that will have broad impact across the drug development and Market Access spectrum.By leveraging SHYFT’s platform, our teams will be able to generate real-time insights spanning strategic consulting to pivotal trial feasibility to late-phase health economics and outcomes research (HEOR) analytics with a much higher level of efficiency.SHYFT will be joining PAREXEL at booth #211 at the ISPOR Europe 2018 conference focused on health economics and outcomes research (HEOR), taking place in Barcelona November 10-14.We simplify our clients’ journey of transforming scientific discoveries into new medical treatments for patients with high-quality Phase I-IV clinical research, regulatory, consulting and market access services.
Classifications
AskAI Classifications
LabelsLinked Companies
